Brielle Benyon

The FDA granted a regular approval to sacituzumab govitecan (Trodelvy) for previously treated patients with unresectable locally advanced or metastatic triple-negative breast cancer.

Wearable fitness trackers may boost fitness, quality of life and overall health in childhood cancer survivors.

Patient-reported outcomes (PRO) hold valuable information on how patients are handling cancer treatment. Recent research analyzed which methods of PROs patients prefer.

In this episode of “The Vitals,” we spoke with Jody Koenig Kellas, PhD, department chair and professor, interpersonal, family, and health communication at the University of Nebraska – Lincoln. Her research looked at the communal cancer experience, and gives clinicians direct tips on how they can reframe hope for patients and caregivers.

While there have been advancements in palliative care programs and clinician education, more still needs to be done, one expert says.

A recent study found that cultural awareness among nurses is not enough. Clinicians need more training and resources to improve cancer care for patients with limited English proficiency.

We want to hear from you: what is the limiting factor in managing adverse events in patients with cancer?

Sleep is key to optimal health, and bright white light therapy may help adolescent cancer survivors improve their circadian rhythms.

Here are the key points to know about the National Comprehensive Cancer Network’s guidelines on treating cancer during the COVID-19 pandemic.

As more Americans get vaccinated against COVID-19, new questions arise, such as: how often should cancer survivors who have been vaccinated against the disease be tested for antibodies?

In this episode of “The Vitals,” an oncology nurse practitioner and certified yoga instructor discusses simple mindfulness strategies that can improve resiliency, leading to fewer feelings of clinician burnout.

While some patients are the exception, most should get vaccinated as soon as they are eligible to do so.

The National Comprehensive Cancer Network (NCCN) recently issued guidance on treating patients who have both a diagnosis of cancer and of COVID-19.

In the era of COVID-19, building resiliency and reducing burnout are key goals for many oncology nurses. Mindfulness and yoga can help.

Many nurses are overworked and burnt out, but changes in health policy may be a step toward making things better. One expert explains how.

While nurse burnout is common, there are steps that nurses can take to improve their resiliency and live healthier, happier lives.

Baseline fatigue levels, prior psychosocial history, and cancer treatment may all affect the fatigue trajectory in women with breast cancer.

Certain patient characteristics correlated with a higher rate of fear of cancer recurrence.

This is the third COVID-19 vaccine to be granted emergency use authorization, and is the first single-dose vaccine.

The FDA approved melphalan flufenamide (Pepaxto; melflufen) plus dexamethasone for adults with triple-refractory multiple myeloma.

The FDA approved single-agent frontline cemiplimab-rwlc (Libtayo) for the treatment of patients with advanced non-small cell lung cancer (NSCLC) with a PD-L1 expression of 50% or greater.

Fear of cancer recurrence is a common plight for people after they have completed cancer treatment, and recent research analyzed which patient characteristics were associated with higher rates of fear of recurrence.

Parents of pediatric patients with cancer were more likely to believe COVID-19 misinformation than parents of children without cancer.

Patients with metastatic urothelial carcinoma with higher tumor mutational burden and who experienced immune-related adverse events tended to have higher response rates to immune checkpoint inhibitor.

The COVID-19 pandemic increased rates of stress in the general public, adding to that of survivors who may already be feeling anxious.

The FDA approved umbralisib for the treatment of adults with relapsed/refractory marginal zone lymphoma and adults with relapsed/refractory follicular lymphoma.

Testicular cancer survivors had a higher rate of mental health service utilization than their healthy counterparts.

Hear from other oncology nurses on what their career means to them, and how they overcame challenges in the last year.

The FDA has granted tepotinib (Tepmetko) accelerated approval for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) with MET exon 14-skipping alterations, according to the FDA.